Ensayo clínico

A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation

NCT: NCT07073950 · RECRUITING

ID NCTNCT07073950

EstadoRECRUITING

Fecha de inicio2025-11-24

Finalización2027-05-31

SponsorAstraZeneca (INDUSTRY)

First posted2025-07-20

Last updated2026-09-18

Resumen breve

The purpose of the study is to evaluate the effect of BGF MDI compared with placebo MDI on cardiac and lung function when administered in participants diagnosed with COPD and hyperinflation.

Fuente oficial

Ver en ClinicalTrials.gov →

Datos obtenidos de la API de ClinicalTrials.gov. Para conocer el estado más reciente, consulte el registro oficial.